Application of Optical Methods for Determination of Concentration of Doxorubicin in Blood and Plasma
Open Access
- 18 January 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (2) , 112
Abstract
The aim of presented research is to develop a simple and quick method of spectrophotometric detection for the determination of doxorubicin hydrochloride in blood and plasma. Anthracycline antibiotics are among the most effective antineoplastic agents. However, despite their high efficacy in the treatment of various types of cancer, their administration is limited primarily because they exhibit myocardial toxicity. This may be a limiting factor in the dosage of medications; nevertheless, drugs exhibiting this mechanism of action constitute a very important group of chemotherapeutics. One of the more widely studied antibiotics from the anthracycline group is doxorubicin. It exhibits the highest antineoplastic activity from among a number of derivative compounds. Because of the adverse effects of doxorubicin, especially cardiotoxicity, it is important to maintain control of its concentration in body fluids. The method in the study consists of extraction doxorubicin from the plasma or blood and measurements of the absorbance of light in the visible light range in a DOX solution with respect to a reference sample. The research used blood and plasma samples spiked with doxorubicin to give concentrations in the range of 0.2–10 µg/mL. Obtained LODs were 1.6 µg/mL and 1.2 µg/mL, respectively.Keywords
All Related Versions
This publication has 29 references indexed in Scilit:
- Voltammetric behavior of doxorubicin at a renewable silver-amalgam film electrode and its determination in human urineElectrochimica Acta, 2014
- How the Quantum Efficiency of a Highly Emissive Binuclear Copper Complex Is Enhanced by Changing the Processing SolventLangmuir, 2013
- Nanoparticle Delivery of Cancer DrugsAnnual Review of Medicine, 2012
- Dexrazoxane protects the heart from acute doxorubicin‐induced QT prolongation: a key role forIKsBritish Journal of Pharmacology, 2010
- Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat modelCancer Chemotherapy and Pharmacology, 2008
- Congestive heart failure in patients treated with doxorubicinCancer, 2003
- Voltammetric Behavior of Adriamycin and Its Determination at Ni Ion-Implanted ElectrodeAnalytical Sciences, 1999
- Determination of Doxorubicin and Doxorubicinol in Plasma of Cancer Patients by High-Performance Liquid ChromatographyAnalytical Biochemistry, 1999
- Voltammetric determination of doxorubicin in urine by adsorptive preconcentration and flow injection analysisAnalytica Chimica Acta, 1985
- Determination of adriamycin (doxorubicin) and related fluorescent compounds in rat lymph and gall by high-performance liquid chromatographyJournal of Chromatography A, 1981